Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01992185 · ClinicalTrials.gov registry record · NA
Photocil (Topical) for the Treatment of Vitiligo
A NA study of Vitiligo, sponsored by Applied Biology.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT01992185: Completed NA study of Vitiligo, sponsored by Applied Biology.
NCT01992185 is a NA study of Vitiligo that has completed, run by Applied Biology. The registered enrollment target is 15 participants, below the 1,123-participant average among 15 other Vitiligo trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01992185, a NA study of Vitiligo, has completed, sponsored by Applied Biology.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
Photocil is a topical drug (cream) that selectively delivers Narrow Band - Ultraviolet B (NB-UVB) therapy when exposed to sunlight. Photocil is intended to help protect users from non-therapeutic Ultraviolet B (UVB) radiation while selectively passing wavelengths of light in the NB-UVB range with peak transmission of 308nm. The aim of the study is to assess the safety and efficacy of Photocil in the treatment of vitiligo.
Conditions Studied
Interventions
- DRUG Photocil for Vitiligo
- OTHER Placebo - Sunscreen (SPF 2)
Study Locations (1)
Arizona
- Physicians Institute - Tucson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2013-08 |
| Est. Completion | 2014-12 |
| Phase | NA |
What the finished NCT01992185 record still lists
NCT01992185 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,123-participant average among 15 other Vitiligo trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Vitiligo appearing as the primary indexed condition, and to 2 interventions - of which Photocil for Vitiligo is the first listed.
NCT01992185 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT01992185 about?
NCT01992185 is a clinical study titled "Photocil (Topical) for the Treatment of Vitiligo". Photocil is a topical drug (cream) that selectively delivers Narrow Band - Ultraviolet B (NB-UVB) therapy when exposed to sunlight. Photocil is intended to help protect users from non-therapeutic Ultraviolet B (UVB) radiation while selectively passing wavelengths of light in the NB-UVB range with pe...
What is the current status of trial NCT01992185?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2013-08. Estimated completion is 2014-12.
What conditions does trial NCT01992185 study?
This clinical trial studies the following conditions: Vitiligo.
What interventions are being tested in trial NCT01992185?
The interventions under investigation include: Photocil for Vitiligo (DRUG), Placebo - Sunscreen (SPF 2) (OTHER).
Who is sponsoring clinical trial NCT01992185?
This trial is sponsored by Applied Biology, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01992185 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vitiligo
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01992185's enrollment target sits among peer trials
15 14th of 15 higher than 2 of 15 other Vitiligo trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Vitiligo trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Molecular Changes in Vitiligo After Narrowband Ultraviolet Therapy
COMPLETED · NA
-
Repigmentation of Stable Vitiligo Lesions Using Spray-On Skin™ Cells
COMPLETED · NA
-
A Study of DR-01 in Subjects With Alopecia Areata and Vitiligo
RECRUITING · Phase 1
-
A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitiligo
RECRUITING · Phase 3
-
The Gut and Skin Microbiome in Vitiligo Disease Progression
RECRUITING
-
A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia